. Author manuscript; available in PMC: 2018 Jan 1.

Published in final edited form as: J Cell Biochem. 2016 Jun 21;118(1):15–25. doi: 10.1002/jcb.25617

Table 2.

mAbs that target the components of bone marrow microenvironment.

Target	Antibody	Phase	Status	Identifier
IL-6	Siltuximab	II	C	NCT00911859
VEGF	Bevacizumab	II	C	N01-CM-62209
BAFF	LY2127399	I	C	-
RANKL	Denosumab	III	C	NCT00330759
DKK1	BHQ880	I	C	NCT20050244
IL-6	Siltuximab	II	C	NCT00911859

R: Recruiting; C: Completed; ONR: Ongoing, not recruiting; BAFF: B-cell activating factor;